| Site-specific glycan analysis of the SARS-CoV-2 spike Y Watanabe, JD Allen, D Wrapp, JS McLellan, M Crispin Science 369 (6501), 330-333, 2020 | 1507 | 2020 |
| Quantitative mass imaging of single biological macromolecules G Young, N Hundt, D Cole, A Fineberg, J Andrecka, A Tyler, A Olerinyova, ... Science 360 (6387), 423-427, 2018 | 524 | 2018 |
| SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... Thorax 75 (12), 1089-1094, 2020 | 364* | 2020 |
| Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Y Watanabe, ZT Berndsen, J Raghwani, GE Seabright, JD Allen, ... Nature communications 11 (1), 2688, 2020 | 342 | 2020 |
| Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers T Tokatlian, BJ Read, CA Jones, DW Kulp, S Menis, JYH Chang, ... Science 363 (6427), 649-654, 2019 | 242 | 2019 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184 (5), 1188-1200. e19, 2021 | 155 | 2021 |
| Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle PJM Brouwer, A Antanasijevic, Z Berndsen, A Yasmeen, B Fiala, TPL Bijl, ... Nature Communications 10 (1), 4272, 2019 | 152 | 2019 |
| Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine Y Watanabe, L Mendonça, ER Allen, A Howe, M Lee, JD Allen, H Chawla, ... ACS central science 7 (4), 594-602, 2021 | 132 | 2021 |
| Structure of the Lassa virus glycan shield provides a model for immunological resistance Y Watanabe, J Raghwani, JD Allen, GE Seabright, S Li, F Moser, ... Proceedings of the National Academy of Sciences 115 (28), 7320-7325, 2018 | 110 | 2018 |
| Site-specific glycosylation of virion-derived HIV-1 Env is mimicked by a soluble trimeric immunogen WB Struwe, E Chertova, JD Allen, GE Seabright, Y Watanabe, DJ Harvey, ... Cell reports 24 (8), 1958-1966. e5, 2018 | 108 | 2018 |
| Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva SE Faustini, SE Jossi, M Perez‐Toledo, AM Shields, JD Allen, ... Immunology 164 (1), 135-147, 2021 | 90* | 2021 |
| HIV-1 vaccine design through minimizing envelope metastability L He, S Kumar, JD Allen, D Huang, X Lin, CJ Mann, KL Saye-Francisco, ... Science advances 4 (11), eaau6769, 2018 | 84 | 2018 |
| Sensitive detection of SARS-CoV-2–specific antibodies in dried blood spot samples GL Morley, S Taylor, S Jossi, M Perez-Toledo, SE Faustini, ... Emerging infectious diseases 26 (12), 2970, 2020 | 79 | 2020 |
| Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition JD Allen, Y Watanabe, H Chawla, ML Newby, M Crispin Journal of molecular biology 433 (4), 166762, 2021 | 67 | 2021 |
| Site-specific steric control of SARS-CoV-2 spike glycosylation JD Allen, H Chawla, F Samsudin, L Zuzic, AT Shivgan, Y Watanabe, ... Biochemistry 60 (27), 2153-2169, 2021 | 62 | 2021 |
| Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics A Torrents de la Peña, K Rantalainen, CA Cottrell, JD Allen, MJ van Gils, ... PLoS pathogens 15 (7), e1007920, 2019 | 57 | 2019 |
| Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers Y Aldon, PF McKay, J Allen, G Ozorowski, RF Lévai, M Tolazzi, P Rogers, ... Cell reports 24 (12), 3324-3338. e5, 2018 | 57 | 2018 |
| Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens A Antanasijevic, G Ueda, PJM Brouwer, J Copps, D Huang, JD Allen, ... PLoS Pathogens 16 (8), e1008665, 2020 | 55 | 2020 |
| Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients AM Cook, SE Faustini, LJ Williams, AF Cunningham, MT Drayson, ... Journal of immunological methods 494, 113046, 2021 | 51 | 2021 |
| Networks of HIV-1 envelope glycans maintain antibody epitopes in the face of glycan additions and deletions GE Seabright, CA Cottrell, MJ van Gils, A D'addabbo, DJ Harvey, ... Structure 28 (8), 897-909. e6, 2020 | 45 | 2020 |
